Did you know that your version of Internet Explorer is out of date?
To get the best possible experience using our website we recommend downloading one of the below web browsers.

Internet Explorer 9, Firefox, Chrome, or Safari.

Treatment Access News

CDEC Recommends Reimbursement of Truvada for HIV PrEP Under Public Drug Plans

august 26, 2016

The CADTH Canadian Drug Expert Committee (CDEC) recommends that emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) be reimbursed for use as pre-exposure prophylaxis (PrEP) of human immunodeficiency virus type 1 (HIV-1) in combination with safer sex practices to reduce the risk...

Click here to view full PDF